CD4 and neoplasm: Our observation of increased frequency of Tregs with an activated phenotype combined with dysfunctional TIGIT‐expressing CD4 and CD8 T cells suggests dampening of anti‐tumor T‐cell responses in lymph nodes with established metastases.